Optofluidics, Inc. — Form D/A
Optofluidics, Inc. of BURLINGAME, CA, a company, filed a Form D amendment with the SEC on 2022-12-29. The offering totals $7.0M, of which $7.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-12-29
- Form: D/A
- Accession: 0001762996-22-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $7.0M
- Investors: 11
- Date of first sale: 2022-06-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-451732
Issuer
- Name: Optofluidics, Inc.
- CIK: 0001762996
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1828 EL CAMINO REAL, BURLINGAME, CA, 94010
- Phone: 215-253-5777
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Rick Gordon | Director | Burlingame, CA |
| Shahram Hejazi | Director | Princeton, NJ |
| Joseph Keegan | Director | San Diego, CA |
| William Snider | Director | Bethesda, MD |
| Chad Souvignier | Director | Hayward, CA |
| Rick Gordon | Executive Officer | Burlingame, CA |
| Casey McGlynn | Executive Officer | Palo Alto, CA |
| Robert Wicke | Director | Hayward, CA |
| Robert Wicke | Executive Officer | Hayward, CA |
| Robert Hart | Executive Officer | Baton Rouge, LA |
| Bernardo Cordovez | Executive Officer | Philadelphia, PA |
Other filings by this issuer (3)
More